| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.82 | 0.001 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |